Overview
Michael Cochran is an Oncologist and a Hematologist in Buffalo Grove, Illinois. Dr. Cochran is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Lung Cancer.
His clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
214 Mchenry Rd, Buffalo Grove, IL 60089
801 S Milwaukee Ave, Libertyville, IL 60048
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Regina Stein is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Stein has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.
Jayesh Mehta is a Hematologist in Chicago, Illinois. Dr. Mehta has been practicing medicine for over 39 years and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Robert Bayer is a Hematologist and an Oncologist in Dekalb, Illinois. Dr. Bayer is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Lynch Syndrome, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Cochran isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Cochran isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Cochran isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Cochran isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Cochran isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Cochran isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Cochran isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Cochran isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Cochran isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Deep Vein ThrombosisDr. Cochran isAdvanced. Learn about Deep Vein Thrombosis.
- Experienced
- Acute Eosinophilic PneumoniaDr. Cochran isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Cochran isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Cochran isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Cochran isExperienced. Learn about Adult Immune Thrombocytopenia.